Chinese leading cellular agriculture company CellX raised tens of millions Yuan in its Series A+ financing. This new round is led by multiple strategic investors. ZhenFund had led its angel round of financing.

Founded in 2020, CellX has built R&D platforms across the four major technological pillars of cultivated meat, cell line development, media optimization, novel bioprocess design, and end product innovation. Recently, CellX announced its plan to build China's first cultivated meat pilot production facility, hosting multiple thousand-liter bioreactors.

This round of funds will be mainly used for the industrialization of CellX, including the cultivated meat pilot production facility， procurement of key equipment, and R&D for the commercialization of its technologies.